Chargement en cours...
Severe hepatic dysfunction is associated with venous thromboembolic events in phase 1 clinical trials
INTRODUCTION: Venous thromboembolic events (VTE) are a significant cause of death in patients with cancer. The incidence of VTE is not well characterized in early phase clinical trials of novel antineoplastic agents, or in hepatic dysfunction studies designed for patients with varying degrees of liv...
Enregistré dans:
| Publié dans: | Thromb Res |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4679432/ https://ncbi.nlm.nih.gov/pubmed/26493604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2015.10.024 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|